Laman UtamaCYCCP • NASDAQ
add
Cyclacel Pharmaceuticals Inc Conv. Pref. Shrs
Tutup sebelumnya
$5.80
Julat hari
$5.44 - $6.04
Julat tahun
$3.20 - $17.00
Permodalan pasaran
8.79J USD
Bilangan Purata
788.00
Nisbah P/E
-
Hasil dividen
-
Berita pasaran
Kewangan
Penyata Pendapatan
Hasil
Pendapatan bersih
(USD) | Mac 2025info | Perubahan T/T |
---|---|---|
Hasil | — | — |
Perbelanjaan pengendalian | 5.04J | 14.87% |
Pendapatan bersih | -81.00K | 97.25% |
Margin untung bersih | — | — |
Pendapatan bagi setiap syer | — | — |
EBITDA | -5.03J | -15.66% |
Kadar cukai berkesan | — | — |
Kunci Kira-kira
Jumlah aset
Jumlah liabiliti
(USD) | Mac 2025info | Perubahan T/T |
---|---|---|
Pelaburan tunai dan jangka pendek | 3.45J | 23.30% |
Jumlah aset | 3.73J | -39.43% |
Jumlah liabiliti | 672.00K | -91.97% |
Jumlah ekuiti | 3.06J | — |
Syer tertunggak | 356.36J | — |
Harga kepada buku | 580.00 | — |
Pulangan pada aset | -321.67% | — |
Pulangan pada modal | -2,807.13% | — |
Aliran Tunai
Perubahan bersih dalam tunai
(USD) | Mac 2025info | Perubahan T/T |
---|---|---|
Pendapatan bersih | -81.00K | 97.25% |
Tunai daripada operasi | -3.25J | -572.26% |
Tunai daripada pelaburan | — | — |
Tunai daripada pembiayaan | 3.65J | 4,715.19% |
Perubahan bersih dalam tunai | 313.00K | 153.97% |
Aliran tunai bebas | -8.48J | -2,737.14% |
Perihal
Cyclacel Pharmaceuticals Inc. is a biotechnology firm based in Dundee, Scotland, and Short Hills, New Jersey, developing cancer drugs and treatments. Cyclacel was founded in 1996 by David Lane, Merlin Ventures and Cancer Research Campaign Technology with the University of Dundee and the University of Glasgow. Wikipedia
Diasaskan
13 Ogo 1996
Ibu pejabat
Tapak web
Pekerja
12